HC Wainwright Forecasts Reduced Earnings for Alpha Cognition

Alpha Cognition Inc. (NASDAQ:ACOG) – Equities researchers at HC Wainwright reduced their Q3 2026 EPS estimates for Alpha Cognition in a research report issued on Monday, August 17th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.33) per share for the quarter, down from their prior forecast of ($0.20). HC Wainwright currently has a “Buy” rating and a $20.00 price target on the stock. The consensus estimate for Alpha Cognition’s current full-year earnings is ($1.34) per share. HC Wainwright also issued estimates for Alpha Cognition’s Q4 2026 earnings at ($0.25) EPS, FY2026 earnings at ($1.33) EPS, Q1 2027 earnings at ($0.12) EPS, Q2 2027 earnings at ($0.13) EPS, Q3 2027 earnings at ($0.07) EPS and FY2027 earnings at ($0.31) EPS.

Several other research firms have also weighed in on ACOG. Craig Hallum reissued a “buy” rating and set a $17.00 price objective on shares of Alpha Cognition in a research note on Friday. Wall Street Zen raised shares of Alpha Cognition from a “sell” rating to a “hold” rating in a research note on Saturday. Maxim Group started coverage on shares of Alpha Cognition in a report on Friday, May 29th. They issued a “buy” rating and a $12.00 target price on the stock. Finally, Raymond James Financial initiated coverage on shares of Alpha Cognition in a research report on Friday, July 10th. They set an “outperform” rating and a $20.00 price target on the stock. Four investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Alpha Cognition presently has an average rating of “Buy” and a consensus price target of $17.25.

Alpha Cognition Price Performance

Shares of ACOG stock opened at $8.57 on Wednesday. The stock has a market cap of $186.57 million, a PE ratio of -7.79 and a beta of 2.30. The stock has a 50-day moving average of $7.85 and a 200-day moving average of $6.57. Alpha Cognition has a one year low of $4.50 and a one year high of $10.00.

Alpha Cognition (NASDAQ:ACOG) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.01). Alpha Cognition had a negative net margin of 153.61% and a negative return on equity of 54.60%. The business had revenue of $6.00 million during the quarter, compared to the consensus estimate of $4.38 million.

Hedge Funds Weigh In On Alpha Cognition

Several institutional investors have recently modified their holdings of ACOG. Geode Capital Management LLC bought a new stake in Alpha Cognition during the 2nd quarter worth approximately $112,000. Massar Capital Management LP acquired a new position in shares of Alpha Cognition in the second quarter valued at approximately $116,000. Two Sigma Investments LP acquired a new position in shares of Alpha Cognition in the third quarter valued at approximately $148,000. Connective Capital Management LLC bought a new stake in shares of Alpha Cognition during the third quarter worth $312,000. Finally, ACT Capital Management LLC acquired a new stake in shares of Alpha Cognition during the fourth quarter worth $335,000.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.